MaxCyte (MXCT) director receives RSUs and 49,579 stock options in new grant
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
MAXCYTE, INC. director Brooke William W received equity awards consisting of common stock and stock options. He was granted 30,421 shares of Common Stock in the form of restricted stock units, each representing a right to one share. These RSUs vest on June 17, 2027, if he continues serving as a non-employee director under the company’s Equity Grant Policy. He was also granted stock options for 49,579 shares of Common Stock at an exercise price of $1.13 per share, expiring on June 16, 2036. Following these awards, he directly holds 181,300 shares of Common Stock.
Positive
- None.
Negative
- None.
Insider Trade Summary
2 transactions reported
Mixed
2 txns
Insider
Brooke William W
Role
null
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (right to buy) | 49,579 | $0.00 | -- |
| Grant/Award | Common Stock | 30,421 | $0.00 | -- |
Holdings After Transaction:
Stock Option (right to buy) — 49,579 shares (Direct, null);
Common Stock — 181,300 shares (Direct, null)
Footnotes (1)
- These shares represent restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. This annual grant was made pursuant to the Issuer's Equity Grant Policy for non-employee directors. The shares underlying this grant vest on June 17, 2027, subject to the reporting person's continuous service as of such vesting date.
Key Figures
RSU grant: 30,421 units
Option grant size: 49,579 options
Option exercise price: $1.13 per share
+2 more
5 metrics
RSU grant
30,421 units
Annual equity grant for non-employee director
Option grant size
49,579 options
Stock Option (right to buy) underlying common shares
Option exercise price
$1.13 per share
Conversion or exercise price for stock options
Common shares held after grant
181,300 shares
Total shares following non-derivative transaction
Option expiration
June 16, 2036
Expiration date of stock options
Key Terms
restricted stock units ("RSUs"), Equity Grant Policy, Stock Option (right to buy)
3 terms
restricted stock units ("RSUs") financial
"These shares represent restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share"
Restricted stock units (RSUs) are a company promise to give an employee shares of stock (or cash equivalent) in the future, but only after certain conditions—usually staying with the company for a set time or hitting performance goals—are met. Investors watch RSUs because when they vest they increase the number of shares outstanding and can lead insiders to sell shares, affecting share price, company dilution and the true cost of employee pay.
Equity Grant Policy financial
"This annual grant was made pursuant to the Issuer's Equity Grant Policy for non-employee directors."
Stock Option (right to buy) financial
"Stock Option (right to buy) ... underlying security title: Common Stock"
FAQ
What did director Brooke William W receive in this MAXCYTE (MXCT) Form 4 filing?
Director Brooke William W received equity awards in MAXCYTE, INC., including restricted stock units and stock options. The grants are compensation for his service as a non-employee director under the company’s Equity Grant Policy and increase his overall direct equity position.
How many restricted stock units did Brooke William W receive from MAXCYTE (MXCT)?
He received 30,421 restricted stock units, each representing a contingent right to one share of MAXCYTE common stock. These RSUs do not convert immediately; they turn into shares only upon vesting, assuming he continues serving as a non-employee director through the vesting date.
When do the MAXCYTE (MXCT) restricted stock units granted to Brooke William W vest?
The RSUs granted to Brooke William W vest on June 17, 2027, subject to his continuous service. This means he must remain a non-employee director through that date to receive the underlying shares of common stock covered by this annual equity grant.
What stock options were granted to Brooke William W by MAXCYTE (MXCT)?
He was granted stock options covering 49,579 shares of MAXCYTE common stock at an exercise price of $1.13 per share. These options give him the right, but not the obligation, to buy those shares at that price before their stated expiration date.
When do Brooke William W’s MAXCYTE (MXCT) stock options expire?
The stock options reported in this filing expire on June 16, 2036, if not exercised earlier. After that expiration date, he would no longer be able to purchase MAXCYTE common shares at the $1.13 exercise price associated with this option grant.